Pfizer, $PFE, is pulling back on some of its research programs and laying off workers after overestimating Covid-19 product sales, per WSJ.— unusual_whales (@unusual_whales) December 15, 2023
Pfizer, $PFE, is pulling back on some of its research programs and laying off workers after overestimating Covid-19 product sales, per WSJ.